Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Short Term Loans and Advances

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Short Term Loans and Advances History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Short Term Loans and Advances ₹1,031 Cr₹626 Cr₹638 Cr₹486 Cr₹606 Cr

What is the latest Short Term Loans and Advances ratio of NATCO PHARMA ?

The latest Short Term Loans and Advances ratio of NATCO PHARMA is ₹1,031 Cr based on Mar2026 Consolidated results.
Year Short Term Loans and Advances
Mar2026₹1,031 Cr
Mar2025₹626 Cr
Mar2024₹638 Cr
Mar2023₹486 Cr
Mar2022₹606 Cr

How is Short Term Loans and Advances of NATCO PHARMA Trending?

Years Short Term Loans and Advances % Change
Mar2026 ₹1,031 Cr
64.79
Mar2025 ₹626 Cr
-1.96
Mar2024 ₹638 Cr
31.43
Mar2023 ₹486 Cr
-19.89
Mar2022 ₹606 Cr -

Compare Short Term Loans and Advances of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,598.4 Cr -2.8% -14.4% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

-14.4%

-3.2%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses